Start-Up Execs On The Move, February 2015
This article was originally published in Start Up
Executive Summary
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Start-Up Execs
Manuel Litchman, MD
To:Pres. & CEO (January)
From:SVP & Global Program Head, Novartis Pharmaceuticals
Phone:203-535-1456
Ken Knudson
To:VP, Global Sales & Mktg. (January)
From:VP, Global Sales, Cheetah Medical Inc.
Phone:781-895-3235
John Pedersen
To:CEO (January)
From:Senior Healthcare Advisor, The Gores Group
Phone:781-895-3235
W. Michael Kavanaugh, MD
To:CSO & Head, Research & Early Dev. (January)
From:SVP, CSO, Five Prime Therapeutics Inc.
Phone:650-515-3185
Bobby W. Sandage, Jr., PD
To:Pres. & CEO (January)
From:Pres. & CEO, Coronado Biosciences Inc.
Phone:314-690-1441
Deborah Law, DPhil
To:CSO (January)
From:CSO, Ablynx NV
Phone:857-259-3840
Roy Hardiman
To:CBO (January)
From:Co-owner & General Counsel, Woodlands Inc.
Phone:650-416-7700
Ian A. W. Howes
To:CFO (January)
From:CFO & VP, Corp. Dev., Akebia Therapeutics Inc.
Phone:919-328-2020
Michele (Shelly) Trucksis, MD, PhD
To:EVP, CMO (January)
From:Exec. Dir., Merck Research Laboratories
Phone:617-945-9626
Anne-Kirsti Aksnes, PhD
To:VP, Clinical Dev. (January)
From:VP, Clinical Research, Algeta ASA
Phone:+47 6712 2658
Tina Madsen
To:VP, Quality Assurance (January)
From:Dir., Product Quality Assurance, Algeta ASA
Phone:+47 6712 2658
Tute Genonics Inc.
David Mittelman, PhD
To:CSO (January)
From:Co-founder, Arpeggi Inc.
Phone:858-779-4363
Andrew Olson
To:VP, Sales (December)
From:VP, Sales, Great Basin Corp.
Phone:858-779-4363
Christiana Stamoulis
To:CFO & Head, Corp. Dev. (January)
From:SVP & Head, Corp. Strategy & Bus. Dev., Vertex Pharmaceuticals Inc.
Phone:617-863-3679
Start-Up Directors
David Nikodem, PhD
To:Director (January)
Phone:857-214-7242
Alan Lewis, PhD
To:Chairman (January)
Phone:213-359-3179
Global Blood Therapeutics Inc.
Willie L. Brown, Jr.
To:Director (January)
Phone:650-741-7700
Principia BioPharma Inc.
Lewis Shuster
To:Director (January)
Phone:650-416-7700
Scioderm Inc.
Mike Lee
To:Director (December)
Phone:919-328-2020
Start-Up Investors
Piper Jaffray
Matthew O'Brien
To:Principal & Senior Research Analyst (December)
From:Senior Analyst, William Blair & Co. LLC
Phone:800-333-6000
Sofinnova Ventures
Daniel G. Welch
To:Exec. Partner (January)
From:Chmn., Pres. & CEO, InterMune Inc.
Phone:650-681-8420
Wake Forest Innovations
Jeff Brennan
To:VP, Industry Relations & Bus. Dev. (January)
From:SVP, Bus. & Commercial Dev. & CBO, Targacept Inc.
Phone:336-716-8508
Start-Up Advisors
Michael Rogawski, MD, PhD
To:Clinical & Scientific Advisor (December)
Phone:978-709-1946
Jeffrey L. Cummings, MD
To:Alzheimer's Disease Clinical Advisor (January)
Phone:945-632-6630
Martin R. Farlow, MD
To:Alzheimer's Disease Clinical Advisor (January)
Phone:945-632-6630
Sam Gandy, MD, PhD
To:Alzheimer's Disease Clinical Advisor (January)
Phone:945-632-6630
Christina Sampaio, MD, PhD
To:Alzheimer's Disease Clinical Advisor (January)
Phone:945-632-6630
Michael Weiner, MD
To:Alzheimer's Disease Clinical Advisor (January)
Phone:945-632-6630
Julian Adams, PhD
To:Scientific Advisor (January)
Phone:617-588-2600
George Q. Daley, MD, PhD
To:Scientific Advisor (January)
Phone:617-588-2600
Karen Vousden, PhD
To:Scientific Advisor (January)
Phone:617-588-2600
Promotions
Cindy Whitehead
To:CEO (January)
From:Pres. & COO
Phone:918-882-0850
Resignations
Eric Halioua
From:CEO (January)
Phone:+32 10 39 43 00